Dea 161-eea

INFORMATION AND INSTRUCTIONS, DEA FORM 161R - EEA

This application must be completed in triplicate. The original is sent to DEA HQs: Drug Enforcement Administration, Diversion Control Division, Import/Export Unit, 8701 Morrissette Drive, Springfield, VA 22152. See Instructions 5a and 9 for copies two and three.

(1) The name and address of the consignee as shown on this application and on the permit to export must correspond with that shown on the foreign import certificate.

(2) To avoid delays in clearance at the port of export, be sure to enter the correct port on this application. A copy of your export permit is sent directly to the District Director of Customs at the port indicated on the application for comparison with the permit presented for clearance of the shipment. The shipment will not clear at any other port without an amendment of the permit indicating a change to that effect.

(3) The original or an authentic signed and/or notarized copy of the foreign import certificate must accompany this application. If this certificate is in a foreign language, a translation must accompany the application. If this certificate is needed to accomplish entry of the drug into the country of destination, your request for its return to you should accompany the application.

(4) Application should be made in the name of the registered legal entity, as shown on the DEA registration certificate, and signed by a responsible authorized official if a corporation, by a partner, or by the person registered as an individual. Only persons registered to export may be issued export permits. The registrations of manufacturers, distributors, practitioners, researchers, etc. do not entitle them to export controlled substances.

(5) Controlled substances in Schedule I or II, or a narcotic drug in Schedule III or IV may be exported from the United States to a country for subsequent export from that country to another country:

a. Thirty days from the date of exportation from the United States to the first EEA country, the exporter must report the export on the Form DEA 161R-EEA by completing 7c with the actual date of release and actual quantity shipped.

b. Within 30 days after each re-exportation to EEA countries, the U. S. exporter must report the export on the DEA 161R-EEA documenting that such re-exportation has occurred and indicate the consignee, country, date and quantity.

c. Within 30 days after the controlled substance is exported from the first country to the second country or the order is canceled by the second country, the person who exported the controlled substance from the United States must deliver to DEA Headquarters documentation certifying that such export from the first country to the second country has occurred or was refused.

i. The company must provide on company letterhead signed by a responsible company official the following information: (1) Name of the country, (2) actual quantity shipped, (3) actual date shipped, and (4) DEA export permit number for the original export to the first country.

ii. For refused shipments, the company must file a written request with DEA for return, a brief summary of the facts warranting the return, and a DEA Form 357, Application for Import Permit. DEA will evaluate the request and return a response in writing.

(6) Permits will be mailed to the exporter at the address shown at the bottom of the application unless contrary instructions are attached to and made a part of this application.

(7) Identification of Importing Company, drugs of the controlled substance content and the date re-exported should be entered on the application in the following manner:

8a. NAME AND ADDRESS OF IMPORTING COMPANY

8b. NAME AND BASE WEIGHT OF CONTROLLED SUBSTANCE (GRAMS)

8c. DATE RE-EXPORTED

(9) Copy 3 of the Application for Permit to Re-Export among European Economic Area (EEA) Members (Form DEA 161R-EEA) is retained by the registrant.

PRIVACY ACT INFORMATION

AUTHORITY: Section 1003 of the Controlled Substances Act of 1970 (PL-513)

PURPOSE: Control exportation of certain Controlled Substances from the United States.

ROUTINE USES: The Controlled Substances Act Registration Records produces special reports as required for statistical analytical purposes. Disclosures of information from this system are made to the following categories of users for the purposed states:

A. Other Federal law enforcement and regulatory agencies for law enforcement and regulatory purposes.

B. State and local law enforcement and regulatory agencies for law enforcement and regulatory purposes.

C. Persons registered under the Controlled Substances Act (Public Law 91-513).

EFFECT: No permit will be issued.

According to the Paperwork Reduction Act of 1995, no persons are required to respond to a Collection of Information unless it displays a valid OMB control number. The valid OMB control number for this Information Collection is: ????????